Sackler Trust halts donations in UK
March 26, 2019Manufacturing and Production Sackler Trust, arts, culture, donations, funding, gallery, sackler
The Sackler Trust has announced it is suspending all new donations in the UK amid negative publicity linking the family’s …
Sanofi may airlift flu vaccines into UK after Brexit
March 26, 2019Manufacturing and Production EU, France, Sanofi, UK, brexit, channel tunnel, vaccines
French firm Sanofi would airlift flu vaccines into the UK in the case of a highly disruptive exit from the …
Google accused of profiting from misleading dementia supplement ads
March 26, 2019Manufacturing and Production Alzheimer's, dementia, google, pseudomedicine, search engines, tech
Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …
Conducting internal investigations within a pharmaceutical business
March 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Reed Smith, feature, internal investigations, pharma
Though often necessary, internal investigations are seldom smooth or easy. Rosanne Kay, Partner at law firm Reed Smith, outlines a …
Sanofi and Lexicon’s Zynquista denied type 1 diabetes approval by FDA complete response letter
March 25, 2019Sales and Marketing Zynquista. FDA, diabetes, pharma
Sanofi and Lexicon’s Zynquista (sotagliflozin) has hit a hurdle on its way to US approval for the treatment of type …
NICE recommend Takeda’s lymphoma treatment Adcetris
March 25, 2019Sales and Marketing Cancer, NICE, Takeda, UK, lymphoma, oncology, recommendation
Britain’s cost effectiveness body has recommended Takeda’s Adcetris (brentuximab vedotin) for adult patients with CD-30 positive advanced cutaneous T-cell lymphoma …
Africa’s legal cannabis market could generate $7.1 billion each year by 2023
March 25, 2019Sales and Marketing Africa, UN, cannabis, medicnial cannabis, prohibition partners
Africa’s legal cannabis market could generate more than $7.1 billion each year by 2023, according to a report from market …
AZ’s diabetes drug Forxiga secures EU approval for adjunctive use in type 1 patients
March 25, 2019Sales and Marketing AstraZeneca, Forxiga, diabetes, pharma
AstraZeneca has revealed that its sodium-glucose co-transporter 2 (SGLT2) inhibitor Forxiga (dapagliflozin) has secured approval from the European Commission for …
Advertising Standards Authority tells therapists to stop marketing ‘autism cure’
March 25, 2019Sales and Marketing ASA, CEASE therapy, advertising standards authority, anti-vaccines, autism, vaccines
The Advertising Standards Authority (ASA) has told British therapists to stop marketing a sham ‘cure’ for autism. The regulator told …
FDA authorises Jazz Pharma’s sleep disorder therapy Sunosi
March 22, 2019Medical Communications, Sales and Marketing FDA, jazz pharmaceuticals, pharma, sleep apnoea
Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the FDA …
Top Ten most popular articles on Pharmafile.com this week!
March 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Biogen, Eisai, FDA, Merck, NICE, Pfizer, Roche, Sandoz
This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on …
Specialists petition FDA over opioid approval process
March 22, 2019Medical Communications FDA, approval process, opioid crisis, opioids, painkillers
FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …
Tate art galleries will not accept donations from Sacklers
March 22, 2019Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis
The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …
Department of Veteran Affairs to offer Janssen’s esketamine to veterans with depression
March 21, 2019Medical Communications Jannsen, Spravato, VA, depression, esketamine, military, veteran affairs
The United States Department of Veteran Affairs (VA), the federal agency responsible for providing healthcare services to military veterans, is …
Breathing life into COPD research
March 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COPD, GSK, feature
Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest approaches to treating COPD …
Biogen and Eisai discontinue Phase 3 Alzheimer’s trial
March 21, 2019Research and Development Alzheimer's, Biogen, CNS, Eisai, mental health
Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of …
Celgene inks drug discovery deal worth at least £25m with AI firm Exscientia
March 21, 2019Research and Development Celgene, Exscientia, drug discovery, pharma
Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value …
J&J bows to PETA pressure and drops forced swim tests in mice
March 21, 2019Medical Communications J&J, JJ, Johnson & Johnson, PETA, animal welfare, pharma
Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other …
Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease
March 21, 2019Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia
Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …
Venezuela relaunch pharmaceutical industry with Chinese and Russian backing
March 21, 2019Manufacturing and Production China, Maduro, Russia, USA, Venezuela, pharma
President Maduro has pledged to relaunch Venezuela’s pharmaceutical industry, as part of an effort to address shortages of medicines in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
